IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CATTANEO, DARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.392
NA - Nord America 2.981
AS - Asia 1.099
AF - Africa 51
SA - Sud America 33
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 17
Totale 7.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.840
GB - Regno Unito 1.474
IT - Italia 668
CN - Cina 580
SE - Svezia 355
DE - Germania 304
IN - India 166
CA - Canada 131
IE - Irlanda 121
FR - Francia 99
FI - Finlandia 80
KR - Corea 76
TR - Turchia 60
BE - Belgio 48
UA - Ucraina 46
RU - Federazione Russa 42
JP - Giappone 38
SG - Singapore 35
NL - Olanda 32
HK - Hong Kong 31
DK - Danimarca 26
CH - Svizzera 24
ZA - Sudafrica 23
ID - Indonesia 22
EU - Europa 20
ES - Italia 19
VN - Vietnam 19
GR - Grecia 18
AU - Australia 16
IR - Iran 13
CL - Cile 12
BR - Brasile 9
MX - Messico 9
RO - Romania 9
PK - Pakistan 7
AT - Austria 6
CO - Colombia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BW - Botswana 5
MY - Malesia 5
PH - Filippine 5
TW - Taiwan 5
IL - Israele 4
KE - Kenya 4
NG - Nigeria 4
NO - Norvegia 4
SA - Arabia Saudita 4
TH - Thailandia 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
ET - Etiopia 3
GH - Ghana 3
LK - Sri Lanka 3
MA - Marocco 3
MM - Myanmar 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PL - Polonia 3
PT - Portogallo 3
SC - Seychelles 3
BG - Bulgaria 2
PE - Perù 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.596
Salva come PNG Salva come JPEG
Città #
Southend 1.380
Chandler 474
Milan 326
Wilmington 200
Fairfield 186
Ann Arbor 183
Seattle 181
Princeton 167
Dublin 121
Ashburn 120
Dearborn 100
Beijing 94
Boardman 93
Houston 86
Woodbridge 84
Toronto 82
Nanjing 68
Des Moines 65
Cambridge 62
Bengaluru 58
New York 55
Redwood City 55
Phoenix 47
Shenyang 43
Brussels 38
Frankfurt am Main 34
Berlin 29
Istanbul 29
Hanover 28
Zhengzhou 28
Redmond 27
Helsinki 25
Mountain View 25
Shanghai 25
Jinan 24
Guangzhou 23
Ottawa 23
Kiez 21
Changsha 20
Falls Church 20
Hebei 19
San Diego 19
Nanchang 17
Boise 15
Amsterdam 14
Hong Kong 14
Haikou 13
Turin 13
Grafing 12
Norwalk 12
Tianjin 12
Fremont 11
Kunming 11
Paris 11
Rome 11
Seoul 11
Taizhou 11
Chengdu 10
Chicago 10
Nürnberg 10
Central District 9
Durban 9
Tokyo 9
Washington 9
Hangzhou 8
Jiaxing 8
Margão 8
Montreal 8
Munich 8
Andover 7
Athens 7
Brescia 7
Bühl 7
Casorate Primo 7
Ningbo 7
Pune 7
Bitonto 6
Caserta 6
Central 6
Chennai 6
Detroit 6
Granada 6
Hyderabad 6
Johannesburg 6
Los Angeles 6
Mumbai 6
Rho 6
Roxbury 6
Silver Spring 6
Bethesda 5
Citta 5
Dong Ket 5
Gaborone 5
Hefei 5
Jacksonville 5
Kuala Lumpur 5
London 5
Palermo 5
Yokoyama 5
Bergamo 4
Totale 5.262
Salva come PNG Salva come JPEG
Nome #
When food can make the difference : The case of elvitegravir-based co-formulation 275
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples 234
Clinical features and outcomes of HIV patients with coronavirus disease 2019 221
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics? 215
Inflammation and neurological adverse drugs reactions : a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis 211
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients : is it time to revise atazanavir dosages? 209
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine 195
Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: A Narrative Review 177
Effetto "contesto" nel trattamento farmacologico infusivo della depressione resistente: dalla teoria a uno studio sperimentale 165
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 165
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 161
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis 153
Atazanavir-induced severe episodes of kidney stones in an HIV-1-infected subject characterized by a CYP3A poor metabolizer phenotype 149
Determinants of bone diseases in tenofovir-treated HIV patients 146
Serotonin reuptake inhibitors in pregnancy : can genes help us in predicting neonatal adverse outcome? 139
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 128
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting 128
Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients 125
Pharmacovigilance knowledge in family paediatricians. A survey study in Italy 121
Acute generalized exanthematous pustulosis induced by paroxetine in an adolescent girl 119
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 118
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients : an observational study in real-life settings 117
Are non-serious adverse reactions to psychiatric drugs really non-serious ? 115
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations : Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 115
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 114
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 112
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 110
Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study 104
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies : evidence from a safety study with pilot efficacy measures in adult dystrophic patients 101
Selective serotonin reuptake inhibitors’ passage into human milk of lactating women 101
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections 98
Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy 97
Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes 95
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics 94
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 94
Perceptions and patterns of use of generic drugs among Italian family pediatricians : first round results of a web survey 93
Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study 93
Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient 92
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis 92
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? 90
Prolonged inductive effect of rifampicin on linezolid exposure 87
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma 87
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint 86
Different effects of glucocorticoids on darunavir plasma concentrations 85
Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients 84
Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count 83
Is it time to revise linezolid doses in peritoneal dialysis patients? A case series 83
Second generation antipsychotics in 'real-life' paediatric patients : adverse drug reactions and clinical outcomes of drug switch 83
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid 82
Potential benefits and limits of psychopharmacological therapies in pervasive developmental disorders 81
The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir 75
Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots 74
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma 74
The relevance of drug-drug interactions in clinical practice: the case of concomitant boosted protease inhibitors plus alpha-1 blocker administration 74
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples 72
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring 72
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5 72
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir 71
Orlistat: weight lost at cost of HIV rebound 67
Dolutegravir and metformin : a clinically relevant or just a pharmacokinetic interaction? 67
Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women 66
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring 63
Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients : A 2-Year Naturalistic Comparison 62
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression : a case report 62
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial 62
Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis? 61
Pharmacogenetics-based optimisation of atazanavir treatment : potential role of new genetic predictors 59
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action? 58
Therapeutic drug management of linezolid : a missed opportunity for clinicians? 56
Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy? 56
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients 52
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out 48
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 48
Severe hyperbilirubinemia in an HIV-HCV coinfected patient starting the 3D regimen that resolved after TDM-guided atazanavir dose reduction 47
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 47
How relevant is the interaction between dolutegravir and metformin in real life? 46
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 43
Pharmacokinetics of oral anticoagulants in patients with atrial fibrillation and extreme obesity 39
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement 31
Management of diabetes mellitus in people living with HIV: A single-center experience 25
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 24
Does lopinavir really inhibit SARS-CoV-2? 22
Drug-induced liver steatosis in patients with HIV infection 15
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic 14
null 3
null 3
Totale 8.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019150 0 0 0 0 0 0 0 0 0 0 53 97
2019/20201.085 113 31 27 89 63 158 122 92 131 166 41 52
2020/2021905 99 48 53 43 73 72 65 92 87 83 127 63
2021/20221.123 91 39 46 58 65 73 81 57 207 115 46 245
2022/20231.480 179 193 164 143 153 249 33 77 174 17 60 38
2023/2024871 48 84 65 81 233 144 47 59 51 49 10 0
Totale 8.152